AVEO Pharmaceuticals Closes Public Offering
AVEO Pharmaceuticals (NASDAQ: AVEO) today reported that it has
closed its recently announced public offering of common stock. The total
number of shares sold was 7,667,050, comprised of 6,667,000 shares of
common stock initially offered and an additional 1,000,050 shares of
common stock sold pursuant to the underwriters' exercise of their
over-allotment option, at the public offering price of $7.50 per share.
Aggregate net proceeds to the company were approximately $53.8 million,
after deducting underwriting discounts and commissions and estimated
J.P. Morgan Securities LLC acted as sole book-running manager for the
offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc.
acting as co-lead managers.